000177323 001__ 177323
000177323 005__ 20240229133737.0
000177323 0247_ $$2doi$$a10.1002/acr.24808
000177323 0247_ $$2pmid$$apmid:34738320
000177323 0247_ $$2ISSN$$a0893-7524
000177323 0247_ $$2ISSN$$a2151-464X
000177323 0247_ $$2ISSN$$a2151-4658
000177323 0247_ $$2altmetric$$aaltmetric:116736603
000177323 037__ $$aDKFZ-2021-02435
000177323 041__ $$aEnglish
000177323 082__ $$a610
000177323 1001_ $$00000-0002-6331-0992$$aKlimek, Matthias$$b0
000177323 245__ $$aLong-term mortality of patients with osteoarthritis after joint replacement: Prognostic value of pre- and postoperative pain and function.
000177323 260__ $$aNew York, NY [u.a.]$$bWiley$$c2023
000177323 3367_ $$2DRIVER$$aarticle
000177323 3367_ $$2DataCite$$aOutput Types/Journal article
000177323 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1680156858_7804
000177323 3367_ $$2BibTeX$$aARTICLE
000177323 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000177323 3367_ $$00$$2EndNote$$aJournal Article
000177323 500__ $$a2023 Apr;75(4):869-875
000177323 520__ $$aTo investigate whether osteoarthritis (OA)-specific assessment values (i.e. Western Ontario and McMaster University Osteoarthritis Index [WOMAC]) and generic pain and function (visual analog scale [VAS], Hanover Functionality Status Questionnaire [FFbH]) measured before and 12 months after arthroplasty are associated with the risk of long-term mortality in a cohort of patients with advanced OA of the hip or knee.The Ulm Osteoarthritis Study was a prospective cohort study of OA patients with unilateral total hip or knee replacement between January 1995 and December 1996. Correlation coefficients were calculated to describe the agreement between the different assessments. Mortality was assessed during the follow-up period (last update: July 2019). Cox proportional regression models were used to estimate hazard ratios (HRs) for mortality after adjusting for covariates.Arthroplasty was accompanied by a clear reduction in pain and improved function throughout all assessments in the 706 included patients. The results of the adjusted Cox models showed no relationship between baseline and follow-up joint-specific WOMAC assessments and long-term mortality. However, an independent increased risk of mortality was found with generic function assessments. In the final adjusted model, the HR for the 12-month follow-up value was 1.79 (95% confidence interval, 1.24-2.60) in the group with clinically relevant impairment versus the reference group.Poor function based on the generic assessment was associated with increased long-term mortality, suggesting that functional impairments in daily life activities may be more important for long-term survival than OA-specific impairments in this patient group. This article is protected by copyright. All rights reserved.
000177323 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000177323 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000177323 7001_ $$aBüchele, Gisela$$b1
000177323 7001_ $$aRehm, Martin$$b2
000177323 7001_ $$aBeyersmann, Jan$$b3
000177323 7001_ $$aGünther, Klaus-Peter$$b4
000177323 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5$$udkfz
000177323 7001_ $$aStürmer, Til$$b6
000177323 7001_ $$00000-0002-5730-9792$$aBrenner, Rolf E$$b7
000177323 7001_ $$00000-0002-3563-2791$$aRothenbacher, Dietrich$$b8
000177323 773__ $$0PERI:(DE-600)2016713-1$$a10.1002/acr.24808$$gp. acr.24808$$n4$$p869-875$$tArthritis care & research$$v75$$x0893-7524$$y2023
000177323 909CO $$ooai:inrepo02.dkfz.de:177323$$pVDB
000177323 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000177323 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000177323 9141_ $$y2021
000177323 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2021-01-29$$wger
000177323 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-29
000177323 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-29
000177323 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-29
000177323 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-22$$wger
000177323 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bARTHRIT CARE RES : 2022$$d2023-10-22
000177323 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-22
000177323 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000177323 980__ $$ajournal
000177323 980__ $$aVDB
000177323 980__ $$aI:(DE-He78)C070-20160331
000177323 980__ $$aUNRESTRICTED